Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1

SNB Capital rated Dr. Sulaiman Al Habib stock Overweight

Published on 10/09/2026 at 13:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

SNB Capital rated Dr. Sulaiman Al Habib stock Overweight on October 7, 2026. Q2 profit reached SAR 662.70 million versus SAR 503.30 million in Q1.

Key points in brief

  • SNB Capital rated Dr. Sulaiman Al Habib Medical Services Overweight on October 7, 2026.
  • Second-quarter 2026 net income reached SAR 662.70 million, compared with SAR 503.30 million in the first quarter.
  • The stock was last quoted at SAR 228.70 on Tadawul on October 8, 2026, while market capitalization stood at SAR 80.0 billion.
  • BSF Capital assigned a SAR 240.00 target and a Hold rating on September 20, 2026.
Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1, Illustration mit AI erstellt.
Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1, Illustration mit AI erstellt.

SNB Capital rated Dr. Sulaiman Al Habib Medical Services stock Overweight on October 7, 2026, according to Argaam. The rating gives the Saudi healthcare operator a fresh analyst reference after first-half net income reached SAR 1.16 billion in 2026.

Profit reached SAR 1.16 billion

The earnings sequence shows a higher quarterly profit base. Argaam lists SAR 503.30 million of net income for the first quarter of 2026 and SAR 662.70 million for the second quarter, while first-half profit totaled SAR 1.16 billion.

What does the profit trend show?

Investing.com reports second-quarter revenue of SAR 4,006.45 million, compared with SAR 3,435.76 million in the previous quarter. Net income increased from SAR 503.29 million to SAR 662.66 million across the same quarterly comparison, a rise of 31.59 percent.

The company also carries a substantial market valuation. Its market capitalization was SAR 80.0 billion as of October 8, 2026, based on the latest available quote data, giving the earnings figures a large-cap context within Saudi equities.

Three dated signals for the stock

On May 3, 2026, the company reported first-quarter net income of SAR 503.30 million. On July 26, 2026, it reported first-half net income of SAR 1.16 billion and second-quarter net income of SAR 662.70 million, according to Argaam. On October 7, 2026, the same page listed an Overweight rating from SNB Capital.

Recent corporate dates

Argaam records August 17, 2026 as a cash dividend distribution date and July 30, 2026 as an ex-dividend date. The company declared a cash dividend of SAR 465.50 million, equal to 13.30 percent of capital, for the second quarter of 2026.

Target remains above the last quote

BSF Capital assigned a Hold rating and a SAR 240.00 target on September 20, 2026, as Argaam reported. The last Tadawul quote was SAR 228.70 on October 8, 2026 at 3:19 p.m. AST, leaving the target SAR 11.30 above the quoted price.

Dr. Sulaiman Al Habib Medical Services at a glance

  • Company: Dr. Sulaiman Al Habib Medical Services Group Company
  • ISIN: SA1510P1UMH1
  • Ticker: 4013
  • Primary exchange: Tadawul
  • Last Tadawul quote: SAR 228.70 on October 8, 2026 at 3:19 p.m. AST
  • Market capitalization: SAR 80.0 billion as of October 8, 2026
  • Sector: Health Care
  • Index membership: TASI

Market context: Latest market reports.

More news and analyses on Dr. Sulaiman Al Habib Medical Services stock

Disclaimer...

en | SA1510P1UMH1 | DR. SULAIMAN AL HABIB MEDICAL SERVICES | boerse | 70277063 | bgmi